What question did this study set out to answer?

To understand how APOBEC expression relates to HPV subtypes, clinical outcomes, IFN signaling, and tumor immune microenvironment in cervical cancer.

July 4, 2026Open Access

View Full Paper

20P APOBEC expression, immune contexture, and clinical outcome across HPV subtypes in cervical cancer

KSK. StegerInnsbruck Medical University KRK. RunggerInnsbruck Medical University VWV. WieserInnsbruck Medical University

Key Points

To understand how APOBEC expression relates to HPV subtypes, clinical outcomes, IFN signaling, and tumor immune microenvironment in cervical cancer.
Characterization of APOBEC expression patterns in cervical cancer samples across different HPV subtypes.
Assessment of clinical outcomes correlated with immune microenvironment and interferon signaling.
Identified distinct APOBEC expression patterns linked to specific HPV subtypes.
Noted variation in immune microenvironment composition affecting clinical outcomes.

Abstract

The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC) family links antiviral defense to cancer-associated mutagenesis, yet its immune-associated role in cervical cancer (CC) remains insufficiently understood. We aimed to characterize APOBEC expression patterns in CC in relation to HPV subtype, clinical outcome, interferon (IFN) signaling, and tumor immune microenvironment.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Steger et al. (Wed,) studied this question.

synapsesocial.com/papers/6a48a36b89561a0c2d78d5ea https://doi.org/https://doi.org/10.1016/j.esmoop.2026.108045

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper